Loading

Annals of Psychiatry and Mental Health

Changes in Network Structure and Centrality of Depressive and Anxiety Symptoms between the before Peak and COVID-19 Outbreak in the Post-COVID-19 Era

Research Article | Open Access | Volume 12 | Issue 1

  • 1. Department of Military Medical Psychology, Air Force Military Medical University, Xi ‘an, China
  • 2. College of Marxism, Xi ‘an Jiaotong University, Xi ‘an, China
  • 3. School of Construction Machinery, Chang’an University, Xi ‘an, China
  • 4. School of Public Health, Xian Medical College, Xi ‘an, China
  • 5. Psychology Section, Secondary Sanatorium of Air Force Healthcare Center for Special Services, Hangzhou, China
  • #. Joint first authors: Shengjun Wu, Runkang Zhao, Lei Ren
+ Show More - Show Less
Corresponding Authors
Xufeng Liu, Department of Military Medical Psychology, Air Force Military Medical University, Xi ‘an 710032, China, Tel: 13488260462
Abstract

Background: To explore the dynamic network structure and centrality of depressive and anxiety symptoms before the peak of COVID-19 and during the COVID-19 outbreak in the post-COVID-19 era.

Methods: A web-based survey was conducted in two stages: the pre-peak stage in the post-COVID-19 era and the outbreak stage in the post-COVID-19 era. The Patient Health Questionnaire-9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7) scales were used. Network models were created to explore the relationship between psychopathology symptoms both within and across anxiety and depression. Symptom network analysis was conducted to evaluate network and bridge centrality, and the network properties were compared between the pre-peak and the outbreak stage.

Results: A total of 1849 participants in the pre-peak stage and 1363 participants in the COVID-19 outbreak stage in the post-COVID-19 era were recruited. D4 “Fatigue” and A4 “Trouble relaxing” had the highest expected influence during the outbreak stage. D2 “Depressed or sad mood”, D5 “Appetite changes”, and D6 “Feeling of worthlessness” played an important role in the network during the peak of the postpandemic era.

Conclusions: This study provides novel insights into the changes in central features during different COVID-19 stages that could activate the connection between anxiety and depression. Implications for interventions and clinical preventions are discussed.

Keywords

• Depression

• Anxiety

• Network structure

• The post-COVID-19 era

Citations

Wu S, Zhao R, Ren L, Wang Y, Ni S, et al. (2024) Changes in Network Structure and Centrality of Depressive and Anxiety Symptoms between the before Peak and COVID-19 Outbreak in the Post-COVID-19 Era. Ann Psychiatry Ment Health 12(1): 1191.

INTRODUCTION

The COVID-19 pandemic has caused substantial threats to people’s physical health and lives and has triggered psychological distress, such as anxiety and depression [1]. Unlike previous infections, worldwide mass media reports have highlighted the unique threat of COVID-19, increasing people’s psychological distress and panic [2]. A number of recent studies have focused on mental health problems during COVID-19, with the most frequently reported symptoms being depression and anxiety [1,3,4]. In a meta-analysis, researchers found that the prevalence estimates of depression and anxiety display a substantial increase in the general population during the COVID-19 pandemic and are estimated to be 33.7% and 31.9%, respectively [5]. In the postepidemic stage, to stop the spread of the COVID-19 epidemic to campuses, the Ministry of Education requested that the start of school be postponed. College students’ vacation was extended and they stayed at home for a long time; they were forced to reduce going out and were unable to study and participate in social activities normally, which may affect their studies and aggravate their anxiety and depression [6,7]. With the weakening of the epidemic situation in China, the resumption of work and production across the country is being carried out in an orderly manner. However, the psychological crisis produced by the epidemic is still not over, and viral transmission, incubation times, and the care of severely affected patients rightly dominate the news [8]. In China, the epidemic began to resurface in some areas after a stable period and the government took city closure measures. The closure of cities may pose another threat to psychological health (e.g., depression and anxiety). Therefore, it is necessary to correctly assess collateral damage in this postepidemic period, also called the “post-COVID-19 era”, especially mental health problems [9].

Although only recently pioneered by Borsboom and his colleagues [10-12], network analysis has quickly become a hot topic in contemporary clinical psychology. Network analysis can be used to extract the structure of psychiatric disturbances from clinical data [11,13,14]. Additionally, a network model is useful in understanding the mechanism of comorbidities and provides information for clinicians to prevent and treat comorbidities [15,16]. Highly central nodes are thought to maintain the network structure since, once activated, they can quickly spread that activation to the entire system, playing a major role in the onset and/or maintenance of a syndrome or disorder [17-20]. Within the network approach to psychopathology, central nodes have accordingly been theoretically [11], and empirically [21,22], viewed with respect to the prognosis of a disorder.

To date, no published network analysis studies have explored network analysis changes in psychology before and after the closure of cities in the postepidemic era. This study may provide a more fine-grained analysis of the theoretical construct, the between/within-disorder edges, central symptoms and bridge symptoms and provide potential clinical intervention targets.

MATERIALS AND METHODS

Participants

The participants were undergraduate students in Shaanxi Province, China. The data of wave 1 were collected from October 25 to November 29, 2021 and wave 2 from January 5 to 9, 2022 via a Chinese online survey platform (Wenjuanxing). All participants provided informed consent before participation. The final sample consisted of 1849 participants (59% female, mean age = 19.00, SD = 1.32, range = 17–23 years) of wave 1 and 1363 participants (52% female, mean age = 19.77, SD = 1.24, range = 17-23 years) of wave 2.

Measures

Depression symptoms: The Patient Health Questionnaire-9 (PHQ-9) is used to measure the frequency of depressive symptoms in clinical practice and research [23]. The PHQ-9 has 9 items, and the score of each item varies from 0 to 3. The higher the total score is, the higher the severity of depression. The internal consistency of the PHQ-9 in this study was excellent (α = 0.93).

Anxiety symptoms: The Generalized Anxiety Disorder 7-Item Questionnaire (GAD-7) is used to measure the frequency of symptoms of GAD [24]. The GAD-7 has 7 items rated from 0 to 3. The higher the total score is, the higher the level of GAD severity. The internal consistency of the GAD-7 in this study was excellent (α = 0.93).

Network analysis

Statistical analyses were conducted in R-statistical software. We fit Gaussian graphical models (GGMs) to the data (i.e., an undirected network) [25]. We used Spearman correlations as input when estimating the network structure [26,27]. We used unregularized model selection in estimating GGMs [27]. The current network estimation was based on the ggm Mod Select method in the R package qgraph [28]. The network was visualized using the R package qgraph [28].

We calculated the nodes’ expected influence using the R package qgraph [28]. The higher the expected influence, the more central the node is in the network. We also calculated the bridge expected influence via the R package network tools [15]. Higher values for bridge expected influence indicate a greater risk of increasing contagion to other communities [15].

The accuracy of edge weights was assessed by plotting the 95% confidence interval for each edge within the presented networks. The stability of the node expected influence and bridge expected influence was evaluated by calculating the correlation stability (CS) coefficient. The ideal CS coefficient is above .5 and should not be below .25 [29]. We further conducted bootstrapped difference tests for edge weights, the node and bridge expected influence. The aforementioned procedures were conducted via the R package bootnet [29].

Finally, we used the R package Network Comparison Test to compared global strength and the edge weight for the three networks, the node expected influence for the   depression and anxiety networks, and the bridge expected influence for the depression-anxiety network in wave 1 and wave 2. The differences in weight for each edge were compared between the two networks after controlling for multiple tests (Bonferroni- Holm correction of p values) [13].

RESULTS

Comparison of symptom scores in wave 1 and wave 2

For depression, D1, D3, D4 and D5 showed significantly higher mean values in wave 2 than wave 1, while D6 and D7 showed the opposite pattern. For anxiety, 6 symptoms (except A4) showed significantly higher mean values in wave 2 than in wave 1. The total scores of depression and anxiety both showed significantly higher mean values in wave 2 than in wave 1.

Description and differences of depression networks in wave 1 and wave 2

In the depression network in wave 1 (Figure 1a), 25 edges were not zero (69.44%) among 36 possible edges.

Depression networks in wave 1 and wave 2.

Figure 1: Depression networks in wave 1 and wave 2.

The strongest edges were D1-D2 (weight = 0.25), D6-D7 (weight = 0.24), and D1-D7 (weight = 0.23). In the depression network in wave 2 (Figure 1b), 23 edges were not zero (63.89%) among 36 possible edges. The strongest edges were D1-D4 (weight = 0.34), D3-D4 (weight = 0.30), and D7-D8 (weight = 0.28).

For wave 1, D4 and D6 had the highest expected influence. The correlation stability coefficient of the node expected influences in wave 1 was 0.75 (> 0.25). For wave 2, D4 and D7 had the highest expected influence. The correlation stability coefficient of node expected influences in wave 2 was 0.75 (> 0.25). (Figure 1c).

There was no significant difference in the global connectivity of depression networks in wave 1 and wave 2 (global strength [S] = 0.04, wave 1 = 3.85, wave 2 = 3.89, P = 0.35). Only one edge had significantly different weight in wave 1 and wave 2 (P < 0.05; (Figure 1a and Figure 1b): D7-D8 (stronger positive connection in wave 2 than in wave 1). D5, D6, D7 and D8 had significantly different expected influence in the depression networks in wave 1 and wave 2 (Figure 1c).

Depression networks in wave 1 (a) and wave 2 (b). Blue edges represent positive correlations, and red edges represent negative correlations. The thickness of the edge reflects the magnitude of the correlation. Centrality plot depicting the expected influence of depression networks in wave 1 and wave 2 (c) (Figure 1).

Description of and differences in anxiety networks in wave 1 and wave 2

In the anxiety network in wave 1 (Figure 2a), 18 edges were not zero (85.71%) among 21 possible edges. The strongest edges were A2-A3 (weight = 0.31), A1-A2 (weight = 0.26), and A3-A4 (weight = 0.25). In the anxiety network in wave 2 (Figure 1b), 16 edges were not zero (76.19%) among 21 possible edges. The strongest edges were A1-A2 (weight = 0.43), A5-A7 (weight = 0.31), and A4-A5 (weight = 0.31).

For wave 1, A2 and A6 had the highest expected influence. The correlation stability coefficient of the node expected influences in wave 1 was 0.75 (> 0.25). For wave 2, A1 and A4 had the highest expected influence. The correlation stability coefficient of the node expected influences in wave 2 was 0.75 (> 0.25) (Figure 2c).

There was a significant difference in the global connectivity of anxiety networks in wave 1 and wave 2 (Global strength [S] = 0.08, wave 1 = 3.13, wave 2 = 3.21, p < 0.001). Only one edge had significantly different weights in wave 1 and wave 2 (P < 0.05; (Figure 2a and Figure 2b): A1 - A2 (stronger positive connection in wave 2 than in wave 1). A1, A4 and A6 had significantly different expected influences in the anxiety networks in wave 1 and wave 2 (Figure 2c).

Anxiety networks in wave 1 and wave 2.

Figure 2: Anxiety networks in wave 1 and wave 2.

Anxiety networks in wave 1 (a) and wave 2 (b). Blue edges represent positive correlations, and red edges represent negative correlations. The thickness of the edge reflects the magnitude of the correlation. Centrality plot depicting the expected influence of anxiety networks in wave 1 and wave 2 (c) (Figure 2).

Description of and differences in depression-anxiety networks in wave 1 and wave 2

In the network in wave 1 (Figure 3a), 18 between-community edges were not zero (28.57%) among 63 possible edges. The strongest between-community edges were D8-A5 (weight = 0.23), D6-A1 (weight = 0.15), and D5-A4 (weight = 0.13). In the network in wave 2 (Figure 1b), 15 between-community edges were not zero (23.81%) among 63 possible edges. The strongest between-community edges were D2-A1 (weight = 0.17), D2-A6 (weight = 0.16), and D8-A5 (weight = 0.15).

For wave 1, A1, D8 and D6 had the highest bridge expected influence. The correlation stability coefficient of the expected influences of the node bridge in wave 1 was 0.52 (> 0.25). For wave 2, D2, A7 and A6 had the highest bridge expected influence. The correlation stability coefficient of the expected influences of the node bridge in wave 2 was 0.59 (> 0.25) (Figure 3c).

There was no significant difference in the global connectivity of depression-anxiety networks in wave 1 and wave 2 (global strength [S] = 0.02, wave 1 = 7.35, wave 2 = 7.37, p = 0.79). There was no between-community edge had significantly different weights in wave 1 and wave 2. D2 and D6 had significantly different bridge expected influence in the depression-anxiety networks in wave 1 and wave 2 (Figure 3c).

Depression-anxiety networks in wave 1 (a) and wave 2 (b). Blue edges represent positive correlations, and red edges represent negative correlations. The thickness of the edge reflects the magnitude of the correlation. Centrality plot depicting the bridge expected influence of depression-anxiety networks in wave 1 and wave 2 (c) (Figure 3).

Depression-anxiety networks in wave 1 and wave 2.

Figure 3: Depression-anxiety networks in wave 1 and wave 2.

DISCUSSION

The novelty of the current study is its evaluation of the psychopathological symptom changes before the peak of and during the COVID-19 outbreak in the postepidemic period in China. The current study identified centrality and bridge symptoms and aimed to identify the risks of co-occurrence between anxiety and depressive symptoms during different phrases of the post- COVID-19 era to prevent increasing psychological depression and anxiety.

Comparison of symptom scores in wave 1 and wave 2

The total scores of depression and anxiety both showed significantly higher mean values in wave 2 than in wave 1. The scores of 4 depression symptoms and 6 anxiety symptoms showed significantly higher in wave 2 than in wave 1. The closure of the city in the later stage of the epidemic further worsened the mental health of college students, which can be seen from the total score of anxiety and depression and the score of each symptom reflected in the results of this study. Researchers have suggested that the mental health consequences of COVID-19 could last over time and that mental health problems could peak later than the actual pandemic [30]. Our results are consistent with the prediction and show that after the COVID-19 peak, the prevalence of depression and anxiety increased. This could be due to the far-reaching influences of COVID-19, such as the induced economic uncertainty, the fear of economic crisis and recession, and increased unemployment [31].

Description and differences of depression networks in wave 1 and wave 2 

Although there was no significant difference in global connectivity, there were actual differences in depression networks between wave 1 and wave 2 (i.e., higher connectivity in wave 2 than wave 1). D7 - D8 had stronger positive connection in wave 2 than wave 1. D4 in the later stage of the epidemic remains the most core symptom in the network, with the centrality of D7 and D8 increasing. In the later stage of the epidemic, fatigue is an important aspect of the mental health of college students, which is consistent with the results of previous study [32]. Fatigue has been shown to have a strong correlation with anhedonia in depression and other psychiatric disorders [33,34]. Interestingly, in the postepidemic stage, after entering the outbreak period, the centrality of mental sports was enhanced, indicating that problems related to mental sports make the mental health problems of college students in closed isolation more prominent. After the peak of the epidemic, normal social activities began to recover and symptoms related to mental movement were relieved accordingly [35]. When people return to a closed isolation state from a gradually recovered life, problems due to psychomotor- related factors continue to appear and increase accordingly. Thus, the importance of psychomotor agitation/delay in the depression network structure may be due to the isolation and lockdown strategies implemented in some countries that cause individuals to feel socially isolated. The results of this study differ from a survey study conducted by Wang et al.[36].Given several studies of psychomotor/delay on the spread of other symptoms, these symptoms have been widely identified as a sign of depression [37-40].

Description of and differences in anxiety networks in wave 1 and wave 2

For wave 1, A2 and A6 had the highest expected influence. For wave 2, A4 and A1 had the highest expected influence. Note that Wang et al. also identified uncontrollable worry and restlessness as highly central nodes in the network structure in their Chinese sample [36] and that Hoffar et al.[41], likewise identified uncontrollable worry (but not restlessness) as the central node in their Norwegian sample. These results are similar to the result of uncontrollable worry as the highest central node in our study. This observation is particularly striking given the varying countries, cultural backgrounds, and political responses vis-à-vis the pandemic between these studies and ours. For decades, research on anxiety has emphasized the determining role of worries in triggering anxiety when one’s concerns are broadly diffuse, future-oriented and related to threats that are not immediately present and may or may not occur, as in the present pandemic context (e.g., worry about the uncertain postpandemic economic recession, worry about possible job loss, worry about uncertain risks of future COVID-19 resurgence) [42-44]. Early results have suggested that worrying during the lockdown, even when adjusting for many other psychological variables, was significantly associated with a higher level of psychological distress and a lower level of life satisfaction during the later phase of the COVID-19 pandemic [45-47]. This view could provide suggestions for the transition of the central node in this study from wave 1 to wave 2.

Description of and differences in depression-anxiety networks in wave 1 and wave 2

In the wave 1, A1 was the most central symptom in the entire network, followed by D8 and D6. As such, these symptoms were the most likely candidates for triggering or maintaining remaining anxiety and depressive symptoms. In the second outbreak stage, the bridge expected influence of these symptoms decreased, but except D6, the bridge expected influence of A1 and D8 was still relatively high compared with other symptoms. The symptoms above could be plausible candidates for hallmark bridge symptoms that contribute to the comorbidity of anxiety and depression. Specific measures related to COVID-19, such as self- isolation, isolation and social distancing, may increase people’s loneliness and emotional problems [48]. Depression and anxiety are frequently co-occurring mental disorders, and previous research has indicated the likelihood of a causal relationship between these two mood disorders [49]. A cognitive neuroscience study using the default model network indicated that cortical areas of the DMN showed functional connectivity associated with anxiety and depression [50]. A previous study suggested that interventions should focus on depression and anxiety symptoms, which are most closely related to other symptoms, since those symptoms should theoretically decrease the associated risk [51]. Moreover, symptoms with high centrality may also have crucial roles in the network [52]. These core symptoms could play important roles in maintaining the psychopathology network, and treating these symptoms could help to cure the psychopathology.

There are also several limitations. First, the results may not be directly generalizable to clinical settings. Secondly, we used the self-report questionnaire in this study, which are subjective to some extent. Third, the current sample was in different time stages and the global application of the results should be fully considered.

CONCLUSION

Thisis the first network analysis to focuson psychopathological symptoms describing changes in the centrality of depressive and anxiety symptoms before the peak and during the COVID-19 outbreak in the post-COVID-19 era. It provides valuable insights to understand the interactions between depression and anxiety. Intervention focused on central symptoms can minimize the overall situation of depression and anxiety.

ACKNOWLEDGEMENTS

Author Contributions

Conceptualization, S.W.,R.Z.,L.R.; methodology, Y.W.; software, S.N.; validation, J.L.; formal analysis, L.W.; investigation, Y.H.; resources, Y.W.; data curation, S.N.; writing—original draft preparation, R.Z., L.R.; writing—review and editing, S.W.,Y.H.; visualization, T.X.; supervision, X.L.; project administration, X.L.; funding acquisition, S.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Key Project of the “14th Five-Year Plan” for Logistics Research (BKJ21J013) and National Natural Science Foundation of China (72374208).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Review Committee of Xijing Hospital (KY20224106-1).

Informed Consent Statement

Informed consent was obtained from all participants involved in the study.

Supplementary materials

Supplementary material associated with this article can be found in the supplementary file.

Data Availability Statement

The datasets presented in this article are not readily available because the datasets involve unfinished research projects.

Acknowledgments

We would like to thank all the individuals who participated in the study. We also thank all the administrative staff and teachers in the university who help us with the recruitment.

REFERENCES
  1. Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendation. Gen Psychiatr. 2020; 33: e100213.
  2. Kim SW, Su KP. Using psychoneuroimmunity against COVID-19. Brain Behav Immun. 2020; 87: 4-5.
  3. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020a; 17: 1729.
  4. Wang C, Pan R, Wan X, Tan Y, Xu L, Mclntyre RS, et al. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav Immun. 2020b; 87: 40-48.
  5. Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021; 1486: 90-111.
  6. Cao W, Fang Z, Hou G, Han M, Xu X, Dong J, et al. The psychological impact of the   COVID-19   epidemic   on   college   students   in China. Psychiatry Res. 2020; 287: 112934.
  7. Chang J, Yuan Y, Wang D. Mental health status and its influencing factors among college students during the epidemic of COVID-19.Nan Fang Yi Ke Da Xue Xue Bao. 2020; 40: 171-176.
  8. Ren FF, Guo RJ. Public Mental Health in Post-COVID-19 Era. Psychiatr Danub. 2020; 32: 251-255.
  9. Lin T, Yi Z, Zhang S, Veldhuis CB. Predictors of Psychological Distress and Resilience in the Post-COVID-19 Era. Int J Behav Med. 2022; 29: 506-516.
  10. Borsboom D. A network theory of mental disorders. World Psychiatry. 2017; 16: 5-13.
  11. Borsboom D, Cramer AO. Network analysis: an integrative approach to the structure of psychopathology. Annu Rev Clin Psychol. 2013; 9: 91-121.
  12. Borsboom D, Cramer AO, Schmittmann VD, Epskamp S, Waldorp LJ. The small world of psychopathology. PLoS One. 2011; 6: e27407.
  13. van Borkulo CD, Borsboom D, Epskamp S, Blanken TF, Boschloo L, Schoevers RA, et al. A new method for constructing networks from binary data. Sci Rep. 2014; 4: 5918.
  14. Epskamp S, Kruis J, Marsman M. Estimating psychopathological networks: Be careful what you wish for. PLoS One. 2017; 12: e0179891.
  15. Jones PJ, Ma R, McNally RJ. Bridge Centrality: A Network Approach to Understanding Comorbidity. Multivariate Behav Res. 2021; 56: 353- 367.
  16. Fried EI, Nesse RM, Zivin K, Guille C, Sen S. Depression is more than the sum score of its parts: individual DSM symptoms have different risk factors. Psychol Med. 2014; 44: 2067-2076.
  17. Barabasi AL, Albert R. Emergence of scaling in   random networks. Science. 1999; 286: 509-512.
  18. Borgatti SP. Centrality and network flow. Soc. Netw. 2005; 27: 55-71.
  19. Blanchard MA, Heeren A. Ongoing and future challenges of the network approach to psychopathology: from theoretical conjectures to clinical translations, in: Asmundson, G. (Ed.), Comprehensive Clinical Psychology. Elsevier; Amsterdam: 2022; 32-46.
  20. McNally RJ. Network Analysis of Psychopathology: Controversies and Challenges. Annu Rev Clin Psychol. 2021; 17: 31-53.
  21. Elliott H, Jones PJ, Schmidt U. Central Symptoms Predict Posttreatment Outcomes and Clinical Impairment in Anorexia Nervosa: A Network Analysis. Clin Psychol Sci. 2020; 8: 139-154.
  22. Papini S, Rubin M, Telch MJ, Smits JAJ, Hien DA. Pretreatment Posttraumatic Stress Disorder Symptom Network Metrics Predict the Strength of the Association Between Node Change and Network Change During Treatment. J Trauma Stress. 2020; 33: 64-71.
  23. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606-613.
  24. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006; 166: 1092-1097.
  25. Epskamp S, Borsboom D, Fried EI. Estimating psychological networks and their accuracy: A tutorial paper. Behav Res Methods. 2018; 50: 195-212.
  26. Epskamp S, Fried EI. A tutorial on regularized partial correlation networks. Psychol Methods. 2018; 23: 617-634.
  27. Isvoranu AM, van Borkulo CD, Boyette LL, Wigman JTW, Vinkers CH, Borsboom D, et al. A Network Approach to Psychosis: Pathways between Childhood Trauma and Psychotic Symptoms. Schizophr Bull. 2017; 43: 187-196.
  28. Epskamp S, Cramer AO, Waldorp LJ, Schmittmann VD, Borsboom D. Qgraph: Network Visualizations of Relationships in Psychometric Data. J Stat Soft. 2012; 48: 1-18.
  29. Epskamp S, Fried EI, van Borkulo CD, Robinaugh DJ, Marsman M, Dalege J, et al. Investigating the Utility of Fixed-margin Sampling in Network Psychometrics. Multivariate Behav Res. 2021; 56: 314-328.
  30. Gunnell D, Appleby L, Arensman E, Hawton K, Johna A, Kapur N, et al. Suicide risk and prevention during the COVID-19 pandemic. Lancet Psychiatry. 2020; 7: 468-471.
  31. Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Losifidis C, et al. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020; 78: 185-193.
  32. Zhao N, Li W, Zhang SF, Yang BX, Sha S, Cheung T, et al. Network Analysis of Depressive Symptoms among Residents of Wuhan in the Later Stage of the COVID-19 Pandemic. Front Psychiatry. 2021; 12: 735973.
  33. Billones RR, Kumar S, Saligan LN. Disentangling fatigue from anhedonia: a scoping review. Transl Psychiatry. 2020; 10: 273.
  34. Klein DF. Endogenomorphic depression. A conceptual and terminological revision. Arch Gen Psychiatry. 1974; 31: 447-454.
  35. K?l?nçel ?, K?l?nçel O, Muratda?? G, Ayd?n A, Usta MB. Factors affecting the anxiety levels of adolescents in home-quarantine during COVID-19 pandemic in Turkey. Asia Pac Psychiatry. 2021; 13: e12406.
  36. Wang Y, Hu Z, Feng Y, Wilson A, Chen R. Changes in network centrality of psychopathology symptoms between the COVID-19 outbreak and after peak. Mol Psychiatry. 2020; 25: 3140-3149.
  37. Ge F, Zheng A, Wan M, Luo G, Zhang J. Psychological State Among the General Chinese Population Before and During the COVID-19 Epidemic: A Network Analysis. Front Psychiatry. 2021; 12: 591656.
  38. Horigome T, Sumali B, Kitazawa M, Yoshimura M, Liang KC, Tazawa Y, et al. Evaluating the severity of depressive symptoms using upper body motion captured by RGB-depth sensors and machine learning in a clinical interview setting: A preliminary study. Compr Psychiatry. 2020; 98: 152169.
  39. Nuño L, Gómez-Benito J, Carmona VR, Pino O. A Systematic Review of Executive Function and Information Processing Speed in Major Depression Disorder. Brain Sci. 2021; 11: 147.
  40. Wang X, Zhou H, Zhu X. Attention deficits in adults with Major depressive disorder: A systematic review and meta-analysis. Asian J Psychiatr. 2020; 53: 102359.
  41. Hoffart A, Johnson SU, Ebrahimi OV. The network of stress-related states and depression and anxiety symptoms during the COVID-19 lockdown. J Affect Disord. 2021; 294: 671-678.
  42. Blix I, Birkeland MS, Thoresen S. Worry and mental health in the Covid-19 pandemic: vulnerability factors in the general Norwegian population. BMC Public Health. 2021; 21: 928.
  43. Cook R, Grimshaw D. A gendered lens on COVID-19 employment and social policies in Europe. Eur Soc. 2021; 23: S215-S227.
  44. Fana M, Torrejón Pérez S, Fernández-Macías E. Employment impact of Covid-19 crisis: from short term effects to long terms prospects. J. Ind. Bus. Econ. 2020; 47: 391-410.
  45. El-Gabalawy R, Sommer JL. “We Are at Risk Too”: The Disparate Mental Health Impacts of the Pandemic on Younger Generations: Nous Sommes Aussi à Risque: Les Effets Disparates de la Pandémie Sur la Santé Mentale des Générations Plus Jeunes. Can J Psychiatry. 2021; 66: 634-644.
  46. Elmer T,   Mepham   K,   Stadtfeld   C.   Students   under   lockdown: Comparisons of students’ social networks and mental health before and during the COVID-19 crisis in Switzerland. PLoS One. 2020; 15: e0236337.
  47. Kämpfen F, Kohler IV, Ciancio A, Bruine de Bruin W, Maurer J, Kohler HP. Predictors of mental health during the Covid-19 pandemic in the US: Role of economic concerns, health worries and social distancing. PLoS One. 2020; 15: e0241895.
  48. WHO, 2020. Mental health and COVID-19.
  49. Frewen PA, Schmittmann VD, Bringmann LF, Borsboom D. Perceived causal relations between anxiety, posttraumatic stress and depression: extension to moderation, mediation, and network analysis. Eur J Psychotraumatol. 2013; 4: 10.
  50. Coutinho JF, Fernandesl SV, Soares JM, Maia L, Gonçalves ÓF, Sampaio A. Default mode network dissociation in depressive and anxiety states. Brain Imaging Behav. 2016; 10: 147-157.
  51. Levinson CA, Zerwas S, Calebs B, Forbush K, Kordy H, Watson H, et al. The core symptoms of bulimia nervosa, anxiety, and depression: A network analysis. J Abnorm Psychol. 2017; 126: 340-354.
  52. Hayes AM, Yasinski C, Ben Barnes J, Bockting CL. Network destabilization and transition in depression: New methods for studying the dynamics of therapeutic change. Clin Psychol Rev. 2015; 41: 27-39.

Wu S, Zhao R, Ren L, Wang Y, Ni S, et al. (2024) Changes in Network Structure and Centrality of Depressive and Anxiety Symptoms between the before Peak and COVID-19 Outbreak in the Post-COVID-19 Era. Ann Psychiatry Ment Health 12(1): 1191.

Received : 27 Jun 2024
Accepted : 19 Jul 2024
Published : 21 Jul 2024
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X